Name: A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats (Video) | JoVE Journal
Uploaded: 2021-02-20T15:00:00.000+00:00
Duration: 5 min 56 s
Description: Learn a reproducible ICU-oriented endotoxin model in rats for sepsis research using arterial and venous catheterization. This method enables repeated physiological and molecular assessments while reducing animal numbers.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

The authors would like to thank Beatrice Beck-Schimmer (MD) and Erik Schadde (MD) for their critical examination and their valuable contribution for this manuscript.

All experiments presented in this protocol were approved by the Veterinary Authorities of the Canton Zurich, Switzerland (approval numbers 134/2014 and ZH088/19). Moreover, all steps performed in this experiment were in accordance with the Guidelines on Experiments with Animals by the Swiss Academy of Medial Sciences (SAMS) and Guidelines of the Federation of European Laboratory Animal Science Associations (FELASA).
1. Anesthesia induction and animal monitoring
<ol>
	<li>Keep male Wistar rats with a weight of 250-300 gram (g) in ventilated cages under pathogen-free conditions. Provide a 12-12-hour light/dark cycle at an ambient temperature of 22 &#177; 1 &#176;C, and free access to food and water.</li>
	<li>Induce general anesthesia either by volatile induction with isoflurane (concentration of 3-5%) in an anesthesia induction box for 30 seconds (Figure 1A) or alternatively, induce anesthesia with a single-shot injection of ketamine/xylazine (10/1 milligram (mg) per 100 g body weight).</li>
	<li>Transfer the animal to a working place and lay the animal on a heating-mat throughout the entire experiment. Keep the body-temperature between 36.5 and 37 &#176;C.</li>
	<li>Use a nosecone to provide oxygen (600 mL/minute). Add isoflurane 2-3% if volatile anesthesia was chosen for anesthesia maintenance. Make sure that the animal is spontaneously breathing.</li>
	<li>Confirm the level of anesthesia by the absence&#160;of the toe-pinch reflex prior to the installation of tracheostomy and arterial and venous catheters.</li>
	<li>Verify a sufficient oxygenation by peripheral oxygen saturation monitoring (normal oxygen saturation 98 - 100%).</li>
	<li>Use an ointment (Vitamin A ointment) to protect the eyes.</li>
	<li>Prepare sterile surgical instruments and catheters on a side table as displayed in Figure 1B.</li>
	<li>Additionally, prepare pressure and oxygen saturation monitoring as displayed in Figure 1C.</li>
</ol>
2. Intravenous access
<ol>
	<li>Apply a tourniquet at the rat&#39;s proximal tail to facilitate venous access (Figure 2A).</li>
	<li>Disinfect the tail 3 times with alcohol.</li>
	<li>Induce a G26 intravenous catheter into one of the two lateral tail veins. 
	NOTE: From our experience it is easier to place the intravenous access at the distal part of the rat&#39;s tail, because the vein here is located closer to the skin. In addition, in case of a failed cannulation, there is enough space to move proximally.</li>
	<li>Strictly avoid air injection.</li>
	<li>Untie the tourniquet after placing the intravenous catheter.</li>
	<li>Fix the intravenous catheter in place with adhesive tape (Figure 2B).</li>
	<li>Connect syringe-pumps to the intravenous access for continuous fluid and drug application.</li>
	<li>Use 3-way stopcocks for bolus fluid, drug application, and venous blood sampling.</li>
</ol>
3. Tracheostomy
<ol>
	<li>Shave the animal&#39;s anterior neck-area.</li>
	<li>Disinfect the shaved skin 3 times with providone-iodine solution.</li>
	<li>Perform a circa 2 cm longitudinal incision using a scalpel (with a blade number 10).</li>
	<li>Retract the skin with 2-0 silk sutures.</li>
	<li>Bluntly prepare the larynx and the trachea with surgical scissors (Figure 3A).</li>
	<li>Make sure to open the trachea with surgical micro&#160;scissors at the 3-5th tracheal clasp.</li>
	<li>Insert a sterile tracheal cannula into the trachea. Be careful, do not insert the cannula too deeply in order to avoid unilateral ventilation.</li>
	<li>Fix the cannula in place using a 2-0 silk suture.</li>
	<li>Connect the cannula to a ventilator for pressure or volume-controlled ventilation (Figure 3B).</li>
</ol>
4. Arterial access
<ol>
	<li>Disinfect the rat tail 3 times with povidone-iodine solution.</li>
	<li>Cut the skin using a scalpel (with a blade number 10) circa 1 cm longitudinally at the ventral side.</li>
	<li>Take care, do not cut too deeply to avoid an injury of the tail artery.</li>
	<li>Use a surgical microscope to expose the artery carefully. Cut the fascia surrounding the artery with surgical micro scissors.</li>
	<li>Ligate the distal part of the artery using a 6-0 silk suture.</li>
	<li>Prepare a proximal 6-0 silk suture but do not tighten the silk (Figure 4A).</li>
	<li>Introduce a G-26 catheter into the artery between the distal and proximal silk suture.</li>
	<li>Once the catheter is in the artery, tighten the proximal silk suture and fix the catheter in place (Figure 4B).</li>
	<li>Connect the catheter to a pressure transducer to provide continuous arterial pressure measurement (normal mean arterial pressure: 60 - 100 mmHg) (Figure 4C).</li>
	<li>Additionally, place a 3-way stopcock between the catheter connected to the pressure transducer and the G-26 catheter for arterial blood sampling.</li>
</ol>
5. Baseline measurement, sepsis induction and follow-up measurements
<ol>
	<li>After the animal reached a steady state, inject the LPS.</li>
	<li>Collect blood samples when a steady state is reached (usually after 15-30 minutes).</li>
	<li>Replace fluid loss from blood samples by Ringer&#39;s solution in a ratio of 1:4.</li>
	<li>To induce sepsis, inject the LPS as a bolus or as a continuous LPS application.</li>
	<li>For the bolus application, inject 1 mg of LPS/kilogram body weight (kg) dissolved in phosphate buffered saline (PBS) at a concentration of 1 mg/mL.</li>
	<li>For continuous application, inject 300 &#181;g of LPS/kg/hour throughout the entire experiment using a syringe pump (stock solution of LPS: 1 mg/mL in PBS).</li>
	<li>Avoid air-injection at all times in order to prevent air embolism.</li>
	<li>Define fluid replacement protocols, vasoconstrictor application protocols, and abortion criteria (for example hypotension defined as a mean arterial blood pressure below 50 mmHg for more than 30 minutes despite fluid replacement) before setting up the experiment. 
	NOTE: We suggest a continuous infusion of Ringer&#39;s solution at a rate of 10 mL/kg/hour.</li>
	<li>Subtract any continuous administration of fluids (e.g., for continuous LPS application) from the amount infused so that the results are comparable with those of the control groups. 
	NOTE: At the end of the experiment, and prior to harvesting any organs such as liver, kidney or spleen for further analyses such as histological or biochemical examination animals can be euthanized by an incision of the inferior cava vein. The recommended method of euthanasia is to bring the animals to a surgical plane of anesthesia prior to incision of the inferior vena cava and injection of ice-cold saline into the left heart, especially if inflammatory markers in organs are to be assessed. Ensure to comply with the legal requirements and local guidelines. To verify sepsis-related organ failure, pro-apoptosis marker like caspase-3 may be analyzed as well as &#945;1-microglobuline to verify tubular damage in the kidneys. The organ specific analysis&#160;of markers like CINC-1, MCP-1 and IL-6 may also provide information about the organ specific inflammatory response.</li>
</ol>

<ol><li>Hotchkiss, R. S., Karl, I. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+pathophysiology+and+treatment+of+sepsis%5BTitle%5D)+AND+%22New+England+Journal+of+Medicine%22%5BJournal%5D)">The pathophysiology and treatment of sepsis.</a> New England Journal of Medicine. 348 (2), 138-150 (2003).</li>
<li>Singer, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+Third+International+Consensus+Definitions+for+Sepsis+and+Septic+Shock+%28Sepsis-3%29%5BTitle%5D)+AND+%22Journal+of+the+American+Medical+Association%22%5BJournal%5D)">The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).</a> Journal of the American Medical Association. 315 (8), 801-810 (2016).</li>
<li>Vincent, J. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Assessment+of+the+worldwide+burden+of+critical+illness%3A+the+intensive+care+over+nations+%28ICON%29+audit%5BTitle%5D)+AND+%22Lancet+Respiratory+Medicine%22%5BJournal%5D)">Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit.</a> Lancet Respiratory Medicine. 2 (5), 380-386 (2014).</li>
<li>Fleischmann, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Assessment+of+Global+Incidence+and+Mortality+of+Hospital-treated+Sepsis.+Current+Estimates+and+Limitations%5BTitle%5D)+AND+%22American+Journal+of+Respiratory+and+Critical+Care+Medicine%22%5BJournal%5D)">Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations.</a> American Journal of Respiratory and Critical Care Medicine. 193 (3), 259-272 (2016).</li>
<li>Kumar, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Duration+of+hypotension+before+initiation+of+effective+antimicrobial+therapy+is+the+critical+determinant+of+survival+in+human+septic+shock%5BTitle%5D)+AND+%22Critical+Care+Medicine%22%5BJournal%5D)">Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.</a> Critical Care Medicine. 34 (6), 1589-1596 (2006).</li>
<li>Gotts, J. E., Matthay, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Sepsis%3A+pathophysiology+and+clinical+management%5BTitle%5D)+AND+%22British+Medical+Journal%22%5BJournal%5D)">Sepsis: pathophysiology and clinical management.</a> British Medical Journal. 353, (2016).</li>
<li>Akira, S., Takeda, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Toll-like+receptor+signalling%5BTitle%5D)+AND+%22Nature+Reviews+Immunology%22%5BJournal%5D)">Toll-like receptor signalling.</a> Nature Reviews Immunology. 4 (7), 499-511 (2004).</li>
<li>Urner, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Insight+into+the+beneficial+immunomodulatory+mechanism+of+the+sevoflurane+metabolite+hexafluoro-2-propanol+in+a+rat+model+of+endotoxaemia%5BTitle%5D)+AND+%22Clinical+and+Experimental+Immunology%22%5BJournal%5D)">Insight into the beneficial immunomodulatory mechanism of the sevoflurane metabolite hexafluoro-2-propanol in a rat model of endotoxaemia.</a> Clinical and Experimental Immunology. 181 (3), 468-479 (2015).</li>
<li>Beck-Schimmer, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Which+Anesthesia+Regimen+Is+Best+to+Reduce+Morbidity+and+Mortality+in+Lung+Surgery%3F%3A+A+Multicenter+Randomized+Controlled+Trial%5BTitle%5D)+AND+%22Anesthesiology%22%5BJournal%5D)">Which Anesthesia Regimen Is Best to Reduce Morbidity and Mortality in Lung Surgery?: A Multicenter Randomized Controlled Trial.</a> Anesthesiology. 125 (2), 313-321 (2016).</li>
<li>Deitch, E. A. Animal models of sepsis and shock: a review and lessons learned. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aDeitch%2C+EA+%22Shock%22">Shock</a>. 9 (1), 1-11 (1998).</li>
<li>Buras, J. A., Holzmann, B., Sitkovsky, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Animal+models+of+sepsis%3A+setting+the+stage%5BTitle%5D)+AND+%22Nature+Reviews+Drug+Discovery%22%5BJournal%5D)">Animal models of sepsis: setting the stage.</a> Nature Reviews Drug Discovery. 4 (10), 854-865 (2005).</li>
<li>Perretti, M., Duncan, G. S., Flower, R. J., Peers, S. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Serum+corticosterone%2C+interleukin-1+and+tumour+necrosis+factor+in+rat+experimental+endotoxaemia%3A+comparison+between+Lewis+and+Wistar+strains%5BTitle%5D)+AND+%22British+Journal+of+Pharmacology%22%5BJournal%5D)">Serum corticosterone, interleukin-1 and tumour necrosis factor in rat experimental endotoxaemia: comparison between Lewis and Wistar strains.</a> British Journal of Pharmacology. 110 (2), 868-874 (1993).</li>
<li>Marechal, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Endothelial+glycocalyx+damage+during+endotoxemia+coincides+with+microcirculatory+dysfunction+and+vascular+oxidative+stress%5BTitle%5D)+AND+%22Shock%22%5BJournal%5D)">Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress.</a> Shock. 29 (5), 572-576 (2008).</li>
<li>Thiemermann, C., Ruetten, H., Wu, C. C., Vane, J. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+multiple+organ+dysfunction+syndrome+caused+by+endotoxin+in+the+rat%3A+attenuation+of+liver+dysfunction+by+inhibitors+of+nitric+oxide+synthase%5BTitle%5D)+AND+%22British+Journal+of+Pharmacology%22%5BJournal%5D)">The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.</a> British Journal of Pharmacology. 116 (7), 2845-2851 (1995).</li>
<li>Osuchowski, M. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Minimum+quality+threshold+in+pre-clinical+sepsis+studies+%28MQTiPSS%29%3A+an+international+expert+consensus+initiative+for+improvement+of+animal+modeling+in+sepsis%5BTitle%5D)+AND+%22Intensive+Care+Medicine+Experimental%22%5BJournal%5D)">Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis.</a> Intensive Care Medicine Experimental. 6 (1), 26(2018).</li>
<li>Fink, M. P., Heard, S. O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Laboratory+models+of+sepsis+and+septic+shock%5BTitle%5D)+AND+%22Journal+of+Surgical+Research%22%5BJournal%5D)">Laboratory models of sepsis and septic shock.</a> Journal of Surgical Research. 49 (2), 186-196 (1990).</li>
<li>Buras, J. A., Holzmann, B., Sitkovsky, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Animal+models+of+sepsis%3A+Setting+the+stage%5BTitle%5D)+AND+%22Nature+Reviews+Drug+Discovery%22%5BJournal%5D)">Animal models of sepsis: Setting the stage.</a> Nature Reviews Drug Discovery. 4 (10), 854-865 (2005).</li>
<li>Balls, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+principles+of+humane+experimental+technique%3A+timeless+insights+and+unheeded+warnings%5BTitle%5D)+AND+%22Altex-Alternatives+to+Animal+Experimentation%22%5BJournal%5D)">The principles of humane experimental technique: timeless insights and unheeded warnings.</a> Altex-Alternatives to Animal Experimentation. 27 (2), 144-148 (2010).</li>
</ol>

The authors have no conflicts of interests with regard to the presented study. Martin Schl&#228;pfer has submitted a patent to mitigate the negative effects of surgery and/or anesthesia for patients using medical gases, particularly oxygen (O2) and carbon dioxide (CO2). He has received unrestricted research grants from Sedana Medical, Sweden, and from Roche, Switzerland, not related to this work.

The protocol described here allows for a highly reproducible, yet simple to learn sepsis model, which can be adapted according the research question. Essential in vivo data referring to organ function such as heart rate, blood pressure, and peripheral arterial oxygen saturation may be collected continuously, and blood sampling may be performed repetitively throughout the experiment. In addition, modifications with regard to fluid replacement protocols and vasopressor support can be installed. Given the hemodynamic stabil...

Sepsis and its more severe form, septic shock, are syndromes on the ground of an infection, resulting in an overshooting inflammatory reaction with the release of cytokines, leading to physiological and biochemical changes with a suppressed immune defense and fatal results1,2. This unbalanced inflammatory reaction results in organ dysfunction and organ failure in various vital organs such as lung, kidney, and liver. With 37%3, sepsis is one of the most common reasons for a patient to be admitted to an intensive care unit (ICU). Mortality of sepsis currently ranges around 20-30%4. Early and effective antibiotic treatment is of utmost importance5. Fluid and vasopressor resuscitation need to be installed early, other than that, treatment is purely supportive6.
Sepsis is defined as a proven or suspected infection with bacteria, fungi, viruses, or parasites, which is accompanied by organ dysfunction. Septic shock criteria are met when a further cardiovascular collapse irresponsive to fluid treatment alone, and a lactate level of more than 2 millimole/liter is present2. Sepsis related organ failure may occur in any organ, but is very common in the cardiovascular system, the brain, the kidney, the liver, and the lung. Most patients suffering from sepsis require endotracheal intubation to secure the patient&#39;s airway, to protect from aspiration, and to apply positive end expiratory ventilation with a high fraction of inspired oxygen to prevent or overcome hypoxia. In order to tolerate a tracheal tube and mechanical ventilation, patients usually require sedation.
Endotoxins, such as lipopolysaccharides (LPS) as a component of the membrane of gram negative bacteria induce a strong inflammatory reaction via the toll-like receptor (TLR) 47. Activation of a defined pathway ensures a stable inflammatory reaction. Cytokines like cytokine induced neutrophil chemoattractant protein 1 (CINC-1), monocyte chemoattractant protein 1 (MCP-1), and interleukin 6 (IL-6) are known as prognostic factors for severity and outcome in this model8. Intravenous LPS application has been successfully used to study various aspects of sepsis in rats8,9.
Treatment of sepsis is still a challenge, particularly due to the lack of predictive animal models. If endotoxemia with activation of systemic inflammation is an adequate model for the development of pharmacological therapies is debatable. However, with the well-known LPS-induced TLR 4 pathway important knowledge can be gained.

<table><tbody><tr><td>2-0 silk sutures</td><td>Ethicon, Sommerville, NJ</td><td>K833</td><td>Standard surgical</td></tr><tr><td>26 intravenous catheter</td><td>Becton Dickinson, Franklin Lakes, NJ</td><td>391349</td><td>Standard anesthesia equipment</td></tr><tr><td>6-0 LOOK black braided silk</td><td>Surgical Specalities Corporation, Wyomissing, PA</td><td>SP114</td><td>Standard surgical</td></tr><tr><td>Alaris Syringe Pump</td><td>Bencton Dickinson</td><td></td><td></td></tr><tr><td>Betadine</td><td>Mundipharma, Basel, Switzerland</td><td>7.68034E+12</td><td>GTIN-number</td></tr><tr><td>Curved fine tips microforceps</td><td>World precision instruments (WPI), Sarasota, FL</td><td>504513</td><td>Facilitates vascular preparation</td></tr><tr><td>Fine tips microforceps</td><td>World precision instruments (WPI), Sarasota, FL</td><td>501976</td><td>Tips need to be polished regularly</td></tr><tr><td>Infinity Delta XL Anesthesia monitoring</td><td>Draeger, L&amp;uuml;beck, Germany</td><td></td><td></td></tr><tr><td>Isoflurane, 250 mL bottles</td><td>Attane, Piramal, Mumbai, India</td><td>LDNI 22098</td><td>Standard vet. equipment</td></tr><tr><td>Ketamine (Ketalar)</td><td>Pfitzer, New York, NY</td><td></td><td></td></tr><tr><td>Lipopolysaccharide (LPS) from &lt;em&gt;Escherichia coli&lt;/em&gt;, serotype 055:B5</td><td>Sigma, Buchs, Switzerland</td><td></td><td></td></tr><tr><td>Q-tips small</td><td>Carl Roth GmbH, Karlsruhe, Germany</td><td>EH11.1</td><td>Standard surgical</td></tr><tr><td>Ringerfundin</td><td>Bbraun, Melsungen, Germany</td><td></td><td></td></tr><tr><td>Tec-3 Isofluorane Vaporizer</td><td>Ohmeda, GE-Healthcare, Chicago, IL</td><td>not available anymore</td><td>Standard vet. equipment</td></tr><tr><td>Xylazine (Xylazin Streuli)</td><td>Streuli AG, Uznach, Switzerland</td><td></td><td></td></tr></tbody></table>

a reproducible intensive care unit-oriented endotoxin model in rats

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Sepsis and septic shock remain the leading cause of death in intensive care units. Despite significant improvements in sepsis management, mortality still ranges between 20 and 30%. Novel treatment approaches in order to reduce sepsis-related multiorgan failure and death are urgently needed. Robust animal models allow for one or multiple treatment approaches as well as for testing their effect on physiological and molecular parameters. In this article, a simple animal model is presented.
First, general anesthesia is induced in animals either with the use of volatile or by intraperitoneal anesthesia. After placement of an intravenous catheter (tail vein), tracheostomy, and insertion of an intraarterial catheter (tail artery), mechanical ventilation is started. Baseline values of mean arterial blood pressure, arterial blood oxygen saturation, and heart rate are recorded.
The injection of lipopolysaccharides (1 milligram/kilogram body weight) dissolved in phosphate-buffered saline induces a strong and reproducible inflammatory response via the toll-like receptor 4. Fluid corrections as well as the application of norepinephrine are performed based on well-established protocols.
The animal model presented in this article is easy to learn and strongly oriented towards clinical sepsis treatment in an intensive care unit with sedation, mechanical ventilation, continuous blood pressure monitoring, and repetitive blood sampling. Also, the model is reliable, allowing for reproducible data with a limited number of animals in accordance with the 3R (reduce, replace, refine) principles of animal research. While animal experiments in sepsis research cannot easily replaced, repetitive measurements allow for a reduction of animals and keeping septic animals anesthetized diminishes suffering.

The system presented allows for endotoxemia with hemodynamically stable animals as reported previously9. While the mean arterial pressure remains stable in animals with, and without LPS stimulation LPS treated animal develop characteristics of sepsis such as a negative base excess and a strong inflammatory reaction measured by plasma cytokines (6 hours after application) such as CINC-1 (867 ng/mL), MCP-1 (5027 ng/mL), and IL-6 (867 ng/mL)8, Figure 5</st...

Here, we present a reproducible intensive care unit-oriented endotoxin model in rats.

Sepsis and septic shock remain the leading cause of death in intensive care units. Despite significant improvements in sepsis management, mortality still ...

a-reproducible-intensive-care-unit-oriented-endotoxin-model-in-rats

Research

JoVE Journal

Medicine

Experimental rat endocarditis model due to methicillin-resistant S. aureus.

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Here, a procedure is described for the establishment of systemic infection in the neonatal rat with cultures of Escherichia coli K1. This non-invasive procedure permits colonization of the gastrointestinal tract, translocation of the pathogen to the systemic circulation, and invasion of the central nervous system at the choroid plexus.

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Encephalopathy of prematurity encompasses the central nervous system abnormalities associated with injury from preterm birth. This report describes a clinically relevant rat model of in utero transient systemic hypoxia-ischemia and intra-amniotic lipopolysaccharide administration (LPS) that mimics chorioamnionitis, and the related impact of infectious stimuli and placental underperfusion on CNS development.

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Intravenous administration of endotoxin reliably elicits dose-dependent physiological and immunological alterations consistent with several pathological states. This reductionist approach permits the investigation, modeling and experimental modification of systemic inflammation and its downstream effects in man.

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

A method for establishing lung infections in immunocompetent rodents is described. With proficiency, this method can be performed quickly and easily to induce stable infection with many isolates of S. pneumoniae, H. influenzae, P. aeruginosa, K. pneumoniae and A. baumannii.

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

This protocol describes a centrally catheterized mouse model of prolonged critical illness. We combine the cecal ligation and puncture method to induce sepsis with the use of a central venous line for fluids, drugs and nutrient administration to mimic the human clinical setting.

Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness

Infection of neonatal mice with bioluminescent E. coli O1:K1:H7 results in a septic infection with significant pulmonary inflammation and lung pathology. Here, we describe procedures to model and further study neonatal sepsis using longitudinal intravital imaging in parallel with enumeration of systemic bacterial burdens, inflammatory profiling, and lung histopathology.

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

We provide a protocol for an experimental endotoxemic shock model in pigs by infusion of lipopolysaccharide.

Lipopolysaccharide Infusion as a Porcine Endotoxemic Shock Model

This protocol describes the development of a neonatal piglet model of acute lung injury that models early pathogenic events occurring in the preterm lung, including sub-adequate surfactant quantity, hyperoxia, high-pressure ventilation, and inflammation, to facilitate understanding of molecular triggers of bronchopulmonary dysplasia and enhance therapeutic translation.

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

In this study, a non-invasive endotracheal instillation technique is demonstrated to develop ALI in rats using a basic laryngoscope to ensure precise LPS delivery to the lungs. The LPS is instilled via an endotracheal tube using a laryngoscope. The magnitude of lung injury is evaluated at multiple time points.

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents

Learn a reproducible ICU-oriented endotoxin model in rats for sepsis research using arterial and venous catheterization. This method enables repeated physiological and molecular assessments while reducing animal numbers.

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Explore More Videos